Institut Paoli-Calmettes
Marseille, Bouches-du Rhône, 13009, France
NCT Number: NCT02865889
Laparoscopic surgery is gaining currency in the field of oncologic care, particularly for colorectal and gynecologic cancers. This innovation could be used either for staging purpose and therefore could steer global therapeutic options or for surgical management only.
Increase knowledge and skills lead to an increase in the number and rate of the women this innovation could be offered. The project team observed a shift from traditional surgical management (abdominal radical surgery) towards laparoscopic with a focus on lymphadenectomy.
This innovation however increases some costs (the surgical stage) but decrease some others (the post surgical stage).
Foreseeing the pace of the dissemination needs to have objective and reliable data about who had access to laparoscopic surgery and who didn't (and why) and accurate assessment of related costs.
This program will focus on uterine cancer (both cervix and corpus).
Looking for future studies?
Notify Me18 year and older
Female
Observational
Marseille, Bouches-du Rhône, 13009, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-
Time frame: 2 years
The following costs were included:Equipment costs,Instrument costs,Operating room costs,Hospital stay
Time frame: 2 years
Comparison of the effectiveness of procedures will take into account conversion rate, complications rate, metastatic and pelvic relapse
Institut Paoli-Calmettes
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05007106
Adenocarcinoma, Adnexal Diseases
Anchorage, Alaska, United States
View Trial DetailsNCT04995809
Endometrial Neoplasms, Female Urogenital Diseases
Manchester, United Kingdom
View Trial DetailsNCT01654458
Adnexal Diseases, Endocrine Gland Neoplasms
New York, United States
View Trial DetailsNCT03270995
Adnexal Diseases, Breast Diseases
Ottawa, Ontario, Canada
View Trial Details